halothane has been researched along with Hepatocellular Carcinoma in 8 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with hepatocellular carcinoma with cirrhosis required intermediate end-tidal isoflurane concentrations; healthy live liver donors required the highest end-tidal isoflurane concentrations to provide sufficient anesthetic depth, as monitored by a target BIS (range, 45-55)." | 1.35 | Bispectral index monitoring in healthy, cirrhotic, and end-stage liver disease patients undergoing hepatic operation. ( Chen, CL; Chen, KH; Cheng, KW; Cheng, YF; Chiu, KW; Concejero, AM; Huang, CJ; Huang, TL; Jawan, B; Lin, CC; Liu, YW; Wang, CC; Wang, CH; Wang, SH, 2008) |
| "Halothane was tested only at its maximum tolerated dose, and histologic examination was performed only on tumor masses and other grossly abnormal tissues found at necropsy." | 1.26 | Carcinogenicity of halothane in Swiss/ICR mice. ( Baden, JM; Kosek, JC; Mazze, RI; Rice, SA; Wharton, RS, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (75.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, CH | 1 |
| Chen, CL | 1 |
| Cheng, KW | 1 |
| Huang, CJ | 1 |
| Chen, KH | 1 |
| Wang, CC | 1 |
| Concejero, AM | 1 |
| Cheng, YF | 1 |
| Huang, TL | 1 |
| Chiu, KW | 1 |
| Wang, SH | 1 |
| Lin, CC | 1 |
| Liu, YW | 1 |
| Jawan, B | 1 |
| Moreno, AP | 1 |
| Rook, MB | 1 |
| Fishman, GI | 1 |
| Spray, DC | 1 |
| Goto, Y | 1 |
| Dujovne, CA | 1 |
| Shoeman, DW | 1 |
| Arakawa, K | 1 |
| Klaassen, CD | 1 |
| Baden, JM | 1 |
| Mazze, RI | 1 |
| Wharton, RS | 1 |
| Rice, SA | 1 |
| Kosek, JC | 1 |
| Kunz, W | 1 |
| Schaude, G | 1 |
| Thomas, C | 1 |
| Ishii, DN | 1 |
| Corbascio, AN | 1 |
| Jackson, SH | 2 |
8 other studies available for halothane and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Bispectral index monitoring in healthy, cirrhotic, and end-stage liver disease patients undergoing hepatic operation.
Topics: Adult; Aged; Anesthesia, Inhalation; Carcinoma, Hepatocellular; Halothane; Hepatitis B, Chronic; Hum | 2008 |
Gap junction channels: distinct voltage-sensitive and -insensitive conductance states.
Topics: Animals; Animals, Newborn; Brain; Carcinoma, Hepatocellular; Cardiovascular Physiological Phenomena; | 1994 |
Hepatotoxicity of general anesthetics on rat hepatoma cells in culture.
Topics: Anesthetics; Carcinoma, Hepatocellular; Cells, Cultured; Ethyl Ethers; Glucuronidase; Halothane; Iso | 1976 |
Carcinogenicity of halothane in Swiss/ICR mice.
Topics: Adenoma; Aging; Animals; Carcinoma, Hepatocellular; Erythrocyte Count; Female; Halothane; Hemoglobin | 1979 |
[The effect of phenobarbital and halogenated hydrocarbons on nitrosamine carcinogenesis].
Topics: Animals; Antineoplastic Agents; Carcinogens; Carcinoma, Hepatocellular; Drug Synergism; Halothane; H | 1969 |
Some metabolic effects of halothane on mammalian tissue culture cells in vitro.
Topics: Acetates; Animals; Autoradiography; Carbon Isotopes; Carcinoma, Hepatocellular; Culture Techniques; | 1971 |
The metabolic effects of halothane on mammalian hepatoma cells in vitro. I. Inhibition of cell replication.
Topics: Acetates; Animals; Atmospheric Pressure; Carcinoma, Hepatocellular; Cell Division; Cell Survival; Ce | 1972 |
The metabolic effects of halothane on mammalian hepatoma cells in vitro. II. Inhibition of DNA synthesis.
Topics: Animals; Carbon Radioisotopes; Carcinoma, Hepatocellular; Cells, Cultured; Depression, Chemical; DNA | 1973 |